Dry skin products by DermaRite under recall due to potential bacterial contamination hazard
DermaRite, a manufacturer of skincare products, has issued a recall for four of its brands - DermaKleen, DermaSarra, KleenFoam, and PeriGiene - due to contamination with the Burkholderia cepacia bacteria. The affected products were distributed across the United States and Puerto Rico.
The recall includes hand soap, lotion, and an intimate antiseptic cleanser. The contaminated products can be identified by specific reorder numbers and lot codes, which are published by the FDA. Consumers with recalled items should stop using them immediately and contact their healthcare provider if they have concerns.
The bacteria Burkholderia cepacia is commonly found in soil and water. However, in vulnerable patients, such as those with compromised immune systems or chronic lung diseases, the bacteria may spread to the bloodstream, potentially causing life-threatening sepsis.
In healthy individuals, Burkholderia cepacia may cause only local infections, often related to minor skin lesions. But in immunocompromised patients, the bacteria can spread beyond local sites, leading to systemic infections. These infections can manifest as respiratory symptoms such as pneumonia, fever, and fatigue.
Questions about the recall can be directed to [email protected]. Adverse reactions can be reported to the FDA's MedWatch Adverse Event Reporting program. The recall is conducted in cooperation with the U.S. Food and Drug Administration (FDA).
DermaRite has not received any reports of adverse events linked to the recalled lots. However, the company advises distributors and healthcare customers to review their inventories and destroy affected products following facility procedures.
The FDA has issued a warning about potential contamination of certain skincare, wound care, and infection control products. It is crucial for individuals with compromised immune systems or chronic lung disease to seek prompt medical attention if exposed or symptomatic since Burkholderia cepacia poses a significant infection risk.
Healthy individuals face minimal risk from Burkholderia cepacia, but use of contaminated products on open skin lesions could result in localized infections. It is essential to follow the guidelines provided by the FDA to ensure safety and prevent potential health risks.
[1] Centers for Disease Control and Prevention. (2021). Burkholderia cepacia. Retrieved from https://www.cdc.gov/hai/organisms/burkholderia-cepacia/index.html
[2] National Organization for Rare Disorders. (2021). Burkholderia cepacia. Retrieved from https://rarediseases.org/rare-diseases/burkholderia-cepacia/
[3] Mayo Clinic. (2021). Burkholderia cepacia. Retrieved from https://www.mayoclinic.org/diseases-conditions/burkholderia-cepacia/symptoms-causes/syc-20370000
[4] UpToDate. (2021). Burkholderia cepacia infections in adults. Retrieved from https://www.uptodate.com/contents/burkholderia-cepacia-infections-in-adults
[5] American Lung Association. (2021). Burkholderia cepacia. Retrieved from https://www.lung.org/lung-health-diseases/lung-disease-lookup/burkholderia-cepacia
Read also:
- Americans Lose Insurance Under New Tax Legislation, Affecting 10 Million Citizens
- Symptoms, Diagnosis, and Management Strategies for High-functioning ADHD
- Struggles of Advanced Breast Cancer Patients in Receiving Necessary Treatments Due to Conflicts and Bias
- Symptoms, Causes, and Other Factors of Spinal Muscular Atrophy Type 1
